North America Single-Cell Analysis Market

North America Single-Cell Analysis Market Size (2022 to 2027)

The size of the Single-Cell Analysis Market in North America was worth USD 0.83 billion in 2022 and is estimated to be growing at a CAGR of 15.89% to reach USD 1.74 billion by 2027.

Factors such as rising collaborations among important companies, technological developments, and the growing biotechnology and pharmaceutical sectors are expected to promote the North American single-cell analysis market growth. In addition, several government programs have been established in recent years to augment the region's single-cell analysis market growth. This market is being propelled forward by technological advancements in single-cell analysis products, increased government funding for cell-based research, a growing focus on personalized medicine, and the rising incidence and prevalence of chronic and infectious diseases. In addition, the landscape of single-cell omics research, including transcriptomic, epigenomics, and genomics, is changing as a result of technological advancements in sequencing techniques.

The ability to process a large number of samples has been aided by significant advances in sequencing repeatability along with reducing prices. Gene identification, protein identification, and other life science-related fields all benefit from cellular analysis. The improved accuracy of cell imaging and analysis systems aids in the reduction of drug discovery time and cost. Researchers may now comprehensively analyze unknown uncommon cell types due to better single-cell RNA sequencing (scRNAseq). The introduction of the microfluidics approach has considerably increased single-cell genomic, transcriptomic analysis in biomedical research. For cell dissociation and tissue digesting, a large range of microfluidic devices has been modified. Single-cell analysis is intended to lead to more accurate and efficient analysis.

During the forecast period, the high cost of single-cell analysis products is projected to limit North American single-cell analysis market growth to some extent. These technical restrictions are expected to pose a challenge to the North American single-cell analysis market.

This research report on the North American single-cell analysis market has been segmented and sub-segmented into the following categories:

By Cells: 

• Human Cells
• Animal Cells
• Microbial Cells

By Product: 

• Consumables
  • Beads
  • Microplates
  • Reagents
  • Assay Kits
  • Others
• Instruments
  • Flow Cytometers
  • NGS Systems
  • PCR Instruments
  • Others

By Technique: 

• Flow Cytometry
• NGS
• PCR
• Microscopy
• Mass Spectrometry
• Other Techniques

By Application: 

• Research Application
• Medical Application

By Country: 

• The United States
• Canada
• Rest of North America

Geographically, North America dominated the single-cell analysis market in 2020, accounting for the largest revenue. High government financing, increased personal healthcare expenditures, improved awareness, rapid adoption of novel analytical techniques, and the availability of competent employees can all be attributed to this. The United States is a big contributor to North America's dominance and accounts for the largest share among other regions in the U.S.

Exceptionally well-developed healthcare infrastructure, rising public awareness, and increased government and private support for research projects are some of the market's primary driving forces. In addition, the presence of many research organizations evaluating single-cell genomics and proteomics for the investigation of various therapeutic areas such as neuroscience, cancer, and infectious diseases has resulted in the growing use of single-cell analysis methods in diagnostics and therapeutic applications.

Furthermore, single-cell analysis is projected to standardize and automate workflows in clinical diagnostics, providing significant information for real-time cancer monitoring and, eventually, new therapeutic methods for the benefit of patients. This feature is expected to result in a more effective and thorough analysis. As a result, increased spending on cancer research is expected to be one of the market's primary driving forces over the forecast period.

KEY MARKET PLAYERS:

A few of the notable companies operating in the North America single-cell analysis market profiled in the report are Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, General ElectricCompany, Thermo Fisher Scientific, Miltenyi Biotec, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, NanoString Technologies, Agilent Technologies, Abcam Plc, NuGEN Technologies Inc., LumaCyte, PluriSelect Life Science UG & Co. KG, Sysmex Partec, Bio-Techne Corporation, Promega Corporation, 10x Genomics, WaferGen Bio-systems, Bruker, and Fluxion Bioscience.